Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

被引:0
|
作者
Jan J. De Waele
J. Lipman
M. Akova
M. Bassetti
G. Dimopoulos
M. Kaukonen
D. Koulenti
C. Martin
P. Montravers
J. Rello
A. Rhodes
A. A. Udy
T. Starr
S. C. Wallis
J. A. Roberts
机构
[1] Ghent University Hospital,Department of Critical Care Medicine
[2] The University of Queensland,Burns Trauma and Critical Care Research Centre
[3] Royal Brisbane and Women’s Hospital,Attikon University Hospital
[4] Hacettepe University Hospital,Department of Epidemiology and Preventive Medicine, Monash University
[5] Azienda Ospedaliera Universitaria Santa Maria della Misericordia,CIBERES
[6] University of Athens Medical School,Department of Intensive Care and Hyperbaric Medicine
[7] Helsinki University Hospital,undefined
[8] Australian and New Zealand Intensive Care Research Centre (ANZIC RC),undefined
[9] Hospital Nord,undefined
[10] Centre Hospitalier Universitaire Bichat-Claude Bernard,undefined
[11] Vall d’Hebron Institut of Research,undefined
[12] St George’s Healthcare NHS Trust and St George’s University of London,undefined
[13] The Alfred Hospital,undefined
来源
Intensive Care Medicine | 2014年 / 40卷
关键词
β-Lactam antibiotics; Pharmacokinetics; Pharmacodynamics; Critical care;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1340 / 1351
页数:11
相关论文
共 50 条
  • [41] Beta-lactam antibiotics in continuous infusion in critically ill patients response
    Taccone, Fabio Silvio
    Vincent, Jean-Louis
    Jacobs, Frederique
    CRITICAL CARE, 2010, 14 (05):
  • [42] Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients
    An, Guohua
    Creech, C. Buddy
    Wu, Nan
    Nation, Roger L.
    Gu, Kenan
    Nalbant, Demet
    Jimenez-Truque, Natalia
    Fissell, William
    Patel, Pratish C.
    Fishbane, Nicholas
    Watanabe, Amy
    Rolsma, Stephanie
    Kirkpatrick, Carl M. J.
    Landersdorfer, Cornelia B.
    Winokur, Patricia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (06) : 1460 - 1470
  • [43] Re: 'Is a randomized trial of a short course of aminoglycoside added to β-lactam antibiotics for empirical treatment in critically ill patients with sepsis justified?' Pharmacokinetic/pharmacodynamic considerations
    Heffernan, A.
    Lipman, J.
    Roberts, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (06) : 666 - 667
  • [44] Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study
    Meenks, Sjoerd D. D.
    Punt, Nieko
    le Noble, Jos L. M. L.
    Foudraine, Norbert A. A.
    Neef, Kees
    Janssen, Paddy K. C.
    CRITICAL CARE, 2023, 27 (01)
  • [45] Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study
    Sjoerd D. Meenks
    Nieko Punt
    Jos L. M. L. le Noble
    Norbert A. Foudraine
    Kees Neef
    Paddy K. C. Janssen
    Critical Care, 27
  • [46] Target Attainment and Population Pharmacokinetics of Nirmatrelvir/Ritonavir in Critically Ill Adult Patients
    Chen, Na
    Yu, Xuben
    Li, Lu
    Yang, Ping
    Dong, Rong
    Huang, Yizhen
    Ling, Xiao
    Shentu, Qiaoqiao
    Yu, Wenqiao
    Jiang, Saiping
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 4055 - 4065
  • [47] Pharmacokinetic/Pharmacodynamic Considerations of Beta-Lactam Antibiotics in Adult Critically Ill Patients
    Masich, Anne M.
    Heavner, Mojdeh S.
    Gonzales, Jeffrey P.
    Claeys, Kimberly C.
    CURRENT INFECTIOUS DISEASE REPORTS, 2018, 20 (05)
  • [48] Pharmacokinetic/Pharmacodynamic Considerations of Beta-Lactam Antibiotics in Adult Critically Ill Patients
    Anne M. Masich
    Mojdeh S. Heavner
    Jeffrey P. Gonzales
    Kimberly C. Claeys
    Current Infectious Disease Reports, 2018, 20
  • [49] Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients
    Martinez-Casanova, Javier
    Esteve-Pitarch, Erika
    Colom-Codina, Helena
    Gumucio-Sanguino, Victor Daniel
    Cobo-Sacristan, Sara
    Shaw, Evelyn
    Maisterra-Santos, Kristel
    Sabater-Riera, Joan
    Perez-Fernandez, Xose L.
    Rigo-Bonnin, Raul
    Tubau-Quintano, Fe
    Carratala, Jordi
    Padulles-Zamora, Ariadna
    ANTIBIOTICS-BASEL, 2023, 12 (03):
  • [50] Methods to Measure Target Site Penetration of Antibiotics in Critically Ill Patients
    Schwameis, Richard
    Zeitlinger, Markus
    CURRENT CLINICAL PHARMACOLOGY, 2013, 8 (01): : 46 - 58